IDEAYA Biosciences, Inc. Collaboration Agreements
13 Contracts & Agreements
- Clinical Trial Collaboration and Supply Agreement by and between MSD International Business GmbH and IDEAYA Biosciences, Inc., dated as of March 8, 2024 (Filed With SEC on May 7, 2024)
- Clinical Trial Collaboration and Supply Agreement by and between Gilead Sciences, Inc. and IDEAYA Biosciences, Inc. dated as of November 29, 2023 (Filed With SEC on February 20, 2024)
- Amendment No. 1 to Clinical Trial Collaboration and Supply Agreement (Second Pfizer Agreement), dated as of May 12, 2023, by and between Pfizer Inc. and IDEAYA Biosciences, Inc (Filed With SEC on August 10, 2023)
- Amendment No. 4 to Clinical Trial Collaboration and Supply Agreement (Pfizer Agreement), dated as of May 12, 2023, by and between Pfizer Inc. and IDEAYA Biosciences, Inc (Filed With SEC on August 10, 2023)
- Clinical Trial Collaboration and Supply Agreement by and between Amgen Inc. and IDEAYA Biosciences, Inc. made as of July 26, 2022 (Filed With SEC on November 8, 2022)
- Amendment No. 2 to Collaboration, Option and License Agreement between GlaxoSmithKline Intellectual Property (No. 4) Limited and IDEAYA Biosciences, Inc. effective as of January... (Filed With SEC on May 10, 2022)
- Clinical Trial Collaboration and Supply Agreement between Pfizer Inc. and IDEAYA Biosciences, Inc. dated as of March 9, 2022. (Third Pfizer Agreement) (Filed With SEC on May 10, 2022)
- Clinical Trial Collaboration and Supply Agreement between Pfizer Inc. and IDEAYA Biosciences, Inc. dated as of March 9, 2022. (Second Pfizer Agreement) (Filed With SEC on May 10, 2022)
- Amendment No. 1 to Collaboration, Option and License Agreement between GlaxoSmithKline Intellectual Property (No. 4) Limited and IDEAYA Biosciences, Inc. dated as of October 23,... (Filed With SEC on March 18, 2022)
- Amendment No. 3 to Clinical Trial Collaboration and Supply Agreement between Pfizer Inc. and IDEAYA Biosciences, Inc. dated as of August 9, 2021 (Filed With SEC on November 15, 2021)
- Amendment No. 2 to Clinical Trial Collaboration and Supply Agreement between Pfizer Inc. and IDEAYA Biosciences, Inc. dated as of April 8, 2021 (Filed With SEC on May 10, 2021)
- Amendment No. 1 to Clinical Trial Collaboration and Supply Agreement between Pfizer Inc. and IDEAYA Biosciences, Inc. dated as of September 23, 2020 (Filed With SEC on November 12, 2020)
- Clinical Trial Collaboration and Supply Agreement between IDEAYA Biosciences, Inc. and Pfizer Inc. dated as of March 11, 2020 (Filed With SEC on May 12, 2020)
